The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

Quinolinamine     quinolin-2-amine

Synonyms: Aminoquinoline, Fragment 19, PubChem5818, CHEMBL61236, SureCN38775, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Quinolinamine

 

High impact information on Quinolinamine

 

Biological context of Quinolinamine

  • [structure: see text] We have previously described a system of 2-aminoquinoline- and 2-aminoquinazoline-based C-deoxynucleosides (TRIPsides) that are designed to be incorporated into oligomers that can specifically bind in the major groove via Hoogsteen base pairing to any sequence of native DNA [7].
  • We synthesized a series of AQs to define the structure-activity relationships responsible for AQ action against chloroquine-susceptible and -resistant P. falciparum [8].
  • In this paper, we report the synthesis of a series of N-benzylated-2-aminoquinolines by reductive amination of aryl aldehydes with 2-aminoquinoline [9].
  • Three copper(II) complexes of aminoquinoline derivatives, l-glycine-N'-8-quinolylamide (L1), l-alanine-N'-8-quinolylamide (L2), and N-(8-quinolyl) pyridine-2-carboxamide (L3) have been shown to cleave plasmid DNA pBR322 and pUC18 with or without the presence of H(2)O(2)/ascorbate [10].
 

Associations of Quinolinamine with other chemical compounds

References

  1. Quinoline resistance mechanisms in Plasmodium falciparum: the debate goes on. Ward, S.A., Bray, P.G., Hawley, S.R. Parasitology (1997) [Pubmed]
  2. Antimalarial lichenoid tissue reactions in patients with pre-existing lupus erythematosus. Geraminejad, P., Stone, M.S., Sontheimer, R.D. Lupus (2004) [Pubmed]
  3. Simple synthesis of aminoquinoline/ethylaniline copolymer semiconducting nanoparticles. Li, X.G., Hua, Y.M., Huang, M.R. Chemistry (Weinheim an der Bergstrasse, Germany) (2005) [Pubmed]
  4. Identification and specificity studies of small-molecule ligands for SH3 protein domains. Inglis, S.R., Stojkoski, C., Branson, K.M., Cawthray, J.F., Fritz, D., Wiadrowski, E., Pyke, S.M., Booker, G.W. J. Med. Chem. (2004) [Pubmed]
  5. Development of a new class of nonimidazole histamine H(3) receptor ligands with combined inhibitory histamine N-methyltransferase activity. Apelt, J., Ligneau, X., Pertz, H.H., Arrang, J.M., Ganellin, C.R., Schwartz, J.C., Schunack, W., Stark, H. J. Med. Chem. (2002) [Pubmed]
  6. In vitro activities of DU-1102, a new trioxaquine derivative, against Plasmodium falciparum isolates. Basco, L.K., Dechy-Cabaret, O., Ndounga, M., Meche, F.S., Robert, A., Meunier, B. Antimicrob. Agents Chemother. (2001) [Pubmed]
  7. Synthesis of C-nucleosides designed to participate in triplex formation with native DNA: specific recognition of an A:T base pair in DNA. Li, J.S., Gold, B. J. Org. Chem. (2005) [Pubmed]
  8. Aminoquinolines that circumvent resistance in Plasmodium falciparum in vitro. De, D., Krogstad, F.M., Cogswell, F.B., Krogstad, D.J. Am. J. Trop. Med. Hyg. (1996) [Pubmed]
  9. Synthesis of N-benzylated-2-aminoquinolines as ligands for the Tec SH3 domain. Inglis, S.R., Jones, R.K., Booker, G.W., Pyke, S.M. Bioorg. Med. Chem. Lett. (2006) [Pubmed]
  10. Steric effect on the nuclease activity of Cu(II) complexes with aminoquinoline derivatives. Shao, Y., Zhang, J., Tu, C., Dai, C., Xu, Q., Guo, Z. J. Inorg. Biochem. (2005) [Pubmed]
  11. Enzyme-triggered formation of electrochemiluminescent ruthenium complexes. Dong, L., Martin, M.T. Anal. Biochem. (1996) [Pubmed]
  12. Effects of antimalarial drugs on interleukin 1-induced cartilage proteoglycan degradation in-vitro. Rainsford, K.D. J. Pharm. Pharmacol. (1986) [Pubmed]
 
WikiGenes - Universities